A tooth abscess is a surgical problem, not a pharmaceutical one, so we need to stop pretending a bottle of pills can solve a ...

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa ...

Incyte INCY announced new 24-week interim data from the STOP-HS program on pipeline candidate, povorcitinib (INCB54707), in ...

"EADV 25: Sanofi’s brivekimig success in Phase IIa HS trial" was originally created and published by Clinical Trials Arena, a ...